No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs149201957 |
chr21:45137769-45137770 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs2002483 |
chr21:45137805-45137806 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
8 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs547856641 |
chr21:45137830-45137831 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs566134720 |
chr21:45137847-45137848 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs2002482 |
chr21:45137853-45137854 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs533010119 |
chr21:45137870-45137871 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs201953455 |
chr21:45137896-45137897 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs140673894 |
chr21:45137901-45137902 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs374154544 |
chr21:45137979-45137980 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs537671126 |
chr21:45137996-45137997 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs377685855 |
chr21:45138009-45138010 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs574648572 |
chr21:45138058-45138059 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
10 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs535972577 |
chr21:45138080-45138081 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
11 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs554260833 |
chr21:45138096-45138097 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
11 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs572480333 |
chr21:45138106-45138107 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
11 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs546169295 |
chr21:45138116-45138117 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs1107204 |
chr21:45138118-45138119 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
18 |
rs576660352 |
chr21:45138124-45138125 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs145753364 |
chr21:45138138-45138139 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs562329826 |
chr21:45138142-45138143 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs529400499 |
chr21:45138193-45138194 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Active TSS
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs1547239 |
chr21:45138200-45138201 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs559808648 |
chr21:45138217-45138218 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs549650982 |
chr21:45138234-45138235 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs527335046 |
chr21:45138252-45138253 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs551412830 |
chr21:45138261-45138262 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs570686941 |
chr21:45138267-45138268 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
12 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs538155237 |
chr21:45138314-45138315 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs531152857 |
chr21:45138355-45138356 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs4819302 |
chr21:45138375-45138376 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs564062349 |
chr21:45138399-45138400 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs549776668 |
chr21:45138415-45138416 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs9981249 |
chr21:45138420-45138421 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs535604525 |
chr21:45138423-45138424 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs554346737 |
chr21:45138447-45138448 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs572567808 |
chr21:45138476-45138477 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs539484721 |
chr21:45138519-45138520 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
14 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs370487789 |
chr21:45138678-45138679 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs72004735 |
chr21:45138710-45138711 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs576330028 |
chr21:45138719-45138720 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs544098649 |
chr21:45138726-45138727 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs67404467 |
chr21:45138733-45138734 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs562006634 |
chr21:45138759-45138760 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs373885341 |
chr21:45138836-45138837 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
18 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs146826482 |
chr21:45138869-45138870 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs71195933 |
chr21:45138877-45138878 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs368052534 |
chr21:45138878-45138879 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionCpG islandChromatin interactive region
|
19 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs62229179 |
chr21:45138930-45138931 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
19 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs564750958 |
chr21:45138952-45138953 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
20 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs559845445 |
chr21:45138988-45138989 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'
|
TF binding regionChromatin interactive region
|
20 gene(s)
|
Overlapped CNVs
|
n/a
|